Brian Poligone

Founder and Medical Director, Rochester Skin Lymphoma Medical Group; Director of Cancer Biology Research; Rochester General Hospital Research Institute

Dr. Poligone is the founder and Medical Director of the Rochester Skin Lymphoma Medical Group and the Director of Cancer Biology Research for the Rochester General Hospital Research Institute, where his research focuses on the underlying mechanism of skin cancers.  With over 50 publications in his specialty, Dr. Poligone has been invited to speak at more than 100 meetings on both his scientific studies and clinical knowledge in the field of lymphoma and skin cancer.  He has also served on a number of NIH review committees. Dr. Poligone completed his internship in Internal Medicine at Stanford University, received his MD and PhD at the University of North Carolina at Chapel Hill and trained at Yale University in the field of cutaneous lymphoma.  Dr. Poligone has enrolled over 40 patients while participating in 4 clinical trials evaluating HyBryte™ photodynamic therapy. As such, has treated more patients with HyBryte than any other physician in the world.